|
gptkbp:instance_of
|
gptkb:Skin
|
|
gptkbp:approves
|
1970s
|
|
gptkbp:available_in
|
various formulations
various strengths
|
|
gptkbp:available_on
|
spray
|
|
gptkbp:brand
|
gptkb:Afrin_Original
gptkb:Afrin_No_Drip
gptkb:Afrin_Severe_Congestion
gptkb:Afrin_Extra_Moisturizing
Afrin Sinus
|
|
gptkbp:clinical_trial
|
Comparative efficacy study
Long-term use study
Nasal congestion relief study
Safety study in children
Side effects monitoring study
|
|
gptkbp:contraindication
|
gptkb:diabetes
hypertension
pregnancy
breastfeeding
heart disease
thyroid disorders
|
|
gptkbp:dosage_form
|
spray bottle
|
|
gptkbp:duration
|
not more than 3 consecutive days
|
|
gptkbp:financial_support
|
Shake well before use
Clear nasal passages before use
Consult doctor if symptoms persist
Do not exceed recommended dose
Not for children under 6 years
|
|
gptkbp:first_introduced
|
1960s
|
|
gptkbp:formulation
|
decongestant
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Afrin
|
|
gptkbp:ingredients
|
oxymetazoline
|
|
gptkbp:is_recommended_for
|
not more than 3 consecutive days
|
|
gptkbp:manufacturer
|
gptkb:Bayer
|
|
gptkbp:mechanism_of_action
|
vasoconstriction
|
|
gptkbp:packaging
|
gptkb:bottle
aerosol can
|
|
gptkbp:regulatory_compliance
|
OTC (over-the-counter)
|
|
gptkbp:related_products
|
gptkb:Claritin
gptkb:Benadryl
gptkb:Sudafed
gptkb:Zicam
Allegra
|
|
gptkbp:route_of_administration
|
nasal
|
|
gptkbp:service_frequency
|
up to 2 times a day
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
sneezing
nasal irritation
dryness of the nasal mucosa
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:symptoms
|
dizziness
headache
nausea
vomiting
increased heart rate
|
|
gptkbp:target_audience
|
adults and children over 6 years
|
|
gptkbp:used_for
|
nasal congestion
|
|
gptkbp:bfsParent
|
gptkb:Syrian_Democratic_Forces
gptkb:Aleppo_Governorate
gptkb:Syrian_Kurdistan
gptkb:Vicks
|
|
gptkbp:bfsLayer
|
5
|